The CELLIMAGE project (2021 – 2024) is funded under the Disruptive Technologies Innovation Fund (DTIF), which is a €500 million fund established under Project Ireland 2040, run by the Department of Enterprise, Trade and Employment with administrative support from Enterprise Ireland.

The opinions expressed by the authors are of their own.

Contact Project Director

paul.dobson@valitacell.com

+353 1 2158130

c/o ValitaCell Ltd, NIBRT, Fosters Avenue, Mount Merrion, Blackrock, A94 X099, Dublin, Ireland